1887

Chapter 20 : Herpes Simplex Viruses

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Herpes Simplex Viruses, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819439/9781555819422.ch20-1.gif /docserver/preview/fulltext/10.1128/9781555819439/9781555819422.ch20-2.gif

Abstract:

Herpes simplex virus (HSV) infections of humans have been documented since the advent of writing. Genital herpes was described in Sumerian literature (1). Greek scholars, particularly Hippocrates, used the word “herpes,” meaning to creep or crawl, to describe the spreading nature of skin lesions (2). Herodotus associated mouth ulcers and lip vesicles with fever and called it “herpes febrilis.” Many of these original observations likely emanated from Galen's deduction that the appearance of lesions was an attempt by the body to rid itself of evil humors, leading to the description “herpes excretins.”

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Schematic representation of the replication of herpes simplex viruses (HSV) in susceptible cells. 1. The virus initiates infection by the fusion of the viral envelope with the plasma membrane following attachment to the cell surface. 2. Fusion of the membranes releases two proteins from the virion. Virus host shutoff (VHS) shuts off protein synthesis (broken RNA in open polyribosomes). The α gene trans-inducing factor (α-TIF) is transported to the nucleus. 3. The capsid is transported to the nuclear pore where viral DNA is released into the nucleus and immediately circularizes. 4. The transcription of α genes by cellular enzymes is induced by α-TIF. 5. The 5 αmRNAs are transported into the cytoplasm and translated (filled polyribosome); the proteins are transported into the nucleus. 6. A new round of transcription results in the synthesis of ß proteins. 7. At this stage in the infection the chromatin (c) is degraded and displaced toward the nuclear membrane, whereas the nucleoli (round hatched structures) become disaggregated. 8. Viral DNA is replicated by a rolling circle mechanism, which yields head-to-tail concatemers of unit length viral DNA. 9. A new round of transcription/translation yields the γ proteins consisting primarily of structural proteins of the virus. 10. The capsid proteins form empty capsids. 11. Unit-length viral DNA is cleaved from concatemers and packaged into the preformed capsids. 12. Capsids containing viral DNA acquire a new protein. 13. Viral glycoproteins and tegument proteins accumulate and form patches in cellular membranes. The capsids containing DNA and the additional protein attach to the underside of the membrane patches containing viral proteins and are enveloped. 14. The enveloped proteins accumulate in the endoplasmic reticulum and are transported into the extracellular space. Reprinted with permission from ( ).

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Seroprevalence of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) by age.

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

Seroprevalence of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) by selected country.

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4
FIGURE 4

Seroprevalence of herpes simplex virus type 2 (HSV-2) as a function of the number of sexual partners.

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 5
FIGURE 5

Histopathology of herpes simplex virus infection.

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 6
FIGURE 6

Schematic diagram of herpes simplex virus (HSV) infection.

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 7
FIGURE 7

Schematic diagram of latency and reactivation.

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 8
FIGURE 8

Sites of herpes simplex virus (HSV) infection and disease.

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 9
FIGURE 9

Herpes simplex gingivostomatitis.

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 10
FIGURE 10

Recurrent herpes simplex labialis.

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 11
FIGURE 11

Genital herpes simplex virus infection (female).

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 12
FIGURE 12

Genital herpes simplex virus infection (male).

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 13
FIGURE 13

Vesicular rash of neonatal herpes simplex virus infection.

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 14
FIGURE 14

Cutaneous dissemination of herpes simplex virus infection in an immunosuppressed host.

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 15
FIGURE 15

Coronal section of brain from patient with herpes simplex encephalitis.

Citation: Whitley R, Roizman B. 2017. Herpes Simplex Viruses, p 415-445. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555819439.ch20
1. Scurlock J, Anderson B. 2005. Diagnosis in Assyrian and Babillonian Medicine. University of Illinois Press, Champaign, IL.
2. Wildy P,. 1973. Herpes: History and classification, p 125. In Kaplan AS (ed), The Herpesviruses. Academic Press, New York.
3. Whitley RJ, Corey L, Arvin A, Mintz E, Lakeman FD, Sumaya CV, Wright PF, Dunkle LM, Steele RW, Soong S-J, Nahmias AJ, Alford CA, Powell DA, San Joaquin V. 1988. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 158:109116.[PubMed]
4. Whitley RJ, Nahmias AJ, Soong SJ, Galasso GG, Fleming CL, Alford CA. 1980. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 66:495501.[PubMed]
5. Dodd K, Johnston LM, Buddingh GJ. 1938. Herpetic stomatitis. J Pediatr 12:95102.
6. Doerr R,. 1938. Herpes Felbrilis, p 4145. In Doerr R, Hallauer C (ed), Handbuch der Virusforschung. Springer, Vienna.
7. Nahmias AJ, Dowdle WR. 1968. Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol 10:110159.[PubMed]
8. Roizman B, Zhou G. 2015. The 3 facets of regulation of herpes simplex virus gene expression: a critical inquiry. Virology 479–480:562567.[PubMed]
9. Han Z, Liu X, Chen X, Zhou X, Du T, Roizman B, Zhou G. 2016. miR-H28 and miR-H29 expressed late in productive infection are exported and restrict HSV-1 replication and spread in recipient cells. Proc Natl Acad Sci USA 113:E894E901.[PubMed]
10. Pellett P, Roizman B,. 2013. Herpesviridae, p 18021822. In Knipe DM, Howley PM (ed), Fields Virology, 6th ed. Lippincott Williams & Wilkins, New York.
11. Roizman B, Taddeo B,. 2007. The strategy of viral replication and takeover of the host cell, p 163174. In Arvin AM, , et al (ed), Human Herpesviruses: Biology, Therapy and Immunoprophylaxis. Cambridge University Press, New York.
12. Knipe DM,. 2001. Herpes simplex viruses and their replication, p 23992459. In Knipe DM, Howley RM (ed), Fields’ Virology. Lippincott Williams & Wilkins, Philadelphia.
13. Roizman B, Pellett PE,. 2001. Herpesviridae, p 23812397. In Knipe DM, Howley RM (ed), Fields’ Virology. Lippincott Williams & Wilkins, Philadelphia.
14. McGeoch DJ, Dalrymple MA, Davison AJ, Dolan A, Frame MC, McNab D, Perry LJ, Scott JE, Taylor P. 1988. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol 69:15311574.[PubMed]
15. Hayward GS, Jacob RJ, Wadsworth SC, Roizman B. 1975. Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components. Proc Natl Acad Sci USA 72:42434247.[PubMed]
16. Roizman B, Knipe DM, Whitley R,. 2007. The replication of herpes simplex viruses, p 25012601. In Knipe DM, , et al (ed), Field's Virology, 5th ed. Lippincott Williams & Wilkins, New York.
17. Knipe DM, Cliffe A. 2008. Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol 6:211221.[PubMed]
18. Roizman B. 2011. The checkpoints of viral gene expression in productive and latent infection: the role of the HDAC/CoREST/LSD1/REST repressor complex. J Virol 85:74747482.[PubMed]
19. Liang Y, Vogel JL, Narayanan A, Peng H, Kristie TM. 2009. Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Nat Med 15:13121317.[PubMed]
20. Gu H, Liang Y, Mandel G, Roizman B. 2005. Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells. Proc Natl Acad Sci USA 102:75717576.[PubMed]
21. Gu H, Roizman B. 2007. Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST-REST complex. Proc Natl Acad Sci USA 104:1713417139.[PubMed]
22. Zhou G, Du T, Roizman B. 2013. The role of the CoREST/REST repressor complex in herpes simplex virus 1 productive infection and in latency. Viruses 5:12081218.[PubMed]
23. Du T, Zhou G, Roizman B. 2011. HSV-1 gene expression from reactivated ganglia is disordered and concurrent with suppression of latency-associated transcript and miRNAs. Proc Natl Acad Sci USA 108:1882018824.[PubMed]
24. Taddeo B, Esclatine A, Roizman B. 2002. The patterns of accumulation of cellular RNAs in cells infected with a wild-type and a mutant herpes simplex virus 1 lacking the virion host shutoff gene. Proc Natl Acad Sci USA 99:1703117036.[PubMed]
25. Taddeo B, Esclatine A, Zhang W, Roizman B. 2003. The stress-inducible immediate-early responsive gene IEX-1 is activated in cells infected with herpes simplex virus 1, but several viral mechanisms, including 3′ degradation of its RNA, preclude expression of the gene. J Virol 77:61786187.[PubMed]
26. Esclatine A, Taddeo B, Roizman B. 2004. Herpes simplex virus 1 induces cytoplasmic accumulation of TIA-1/TIAR and both synthesis and cytoplasmic accumulation of tristetraprolin, two cellular proteins that bind and destabilize AU-rich RNAs. J Virol 78:85828592.[PubMed]
27. Shu M, Taddeo B, Roizman B. 2015. Tristetraprolin recruits the herpes simplex virion host shutoff rnase to au-rich elements in stress response mrnas to enable their cleavage. J Virol 89:56435650.[PubMed]
28. Boutell C, Sadis S, Everett RD. 2002. Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J Virol 76:841850.[PubMed]
29. Chelbi-Alix MK, de Thé H. 1999. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 18:935941.[PubMed]
30. Gu H, Roizman B. 2003. The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a. Proc Natl Acad Sci USA 100:89638968.[PubMed]
31. Chee AV, Lopez P, Pandolfi PP, Roizman B. 2003. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J Virol 77:71017105.[PubMed]
32. Orzalli MH, Conwell SE, Berrios C, DeCaprio JA, Knipe DM. 2013. Nuclear interferon-inducible protein 16 promotes silencing of herpesviral and transfected DNA. Proc Natl Acad Sci USA 110:E4492E4501.[PubMed]
33. He B, Gross M, Roizman B. 1997. The γ134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 94:843848.[PubMed]
34. Roizman B, Whitley R,. 2013. An inquiry into the mechanisms of herpes simplex virus latency and reactivation, p 355374. In Gottesman S, Harwood C, Schneewind O (ed), Annual Review of Microbiology. Annual Reviews, Palo Alto, CA.
35. Roizman B, Zhou G, Du T. 2011. Checkpoints in productive and latent infections with herpes simplex virus 1: conceptualization of the issues. J Neurovirol 17:512517.[PubMed]
36. Kristie TM, Vogel JL, Sears AE. 1999. Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency. Proc Natl Acad Sci USA 96:12291233.[PubMed]
37. La Boissière S, Hughes T, O'Hare P. 1999. HCF-dependent nuclear import of VP16. EMBO J 18:480489.[PubMed]
38. Farrell MJ, Dobson AT, Feldman LT. 1991. Herpes simplex virus latency-associated transcript is a stable intron. Proc Natl Acad Sci USA 88:790794.[PubMed]
39. Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT. 1987. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235:10561059.[PubMed]
40. Amelio AL, McAnany PK, Bloom DC. 2006. A chromatin insulator-like element in the herpes simplex virus type 1 latency-associated transcript region binds CCCTC-binding factor and displays enhancer-blocking and silencing activities. J Virol 80:23582368.[PubMed]
41. Du T, Zhou G, Roizman B. 2013. Modulation of reactivation of latent herpes simplex virus 1 in ganglionic organ cultures by p300/CBP and STAT3. Proc Natl Acad Sci USA 110:E2621E2628.[PubMed]
42. Shu M, Du T, Zhou G, Roizman B. 2015. Role of activating transcription factor 3 in the synthesis of latency-associated transcript and maintenance of herpes simplex virus 1 in latent state in ganglia. Proc Natl Acad Sci USA 112:E5420E5426.[PubMed]
43. Du T, Zhou G, Roizman B. 2012. Induction of apoptosis accelerates reactivation of latent HSV-1 in ganglionic organ cultures and replication in cell cultures. Proc Natl Acad Sci USA 109:1461614621.[PubMed]
44. Kriesel JD, Bhatia A, Thomas A. 2014. Cold sore susceptibility gene-1 genotypes affect the expression of herpes labialis in unrelated human subjects. Hum Genome Variation 1:14024.
45. Cassady KA, Gross M, Roizman B. 1998. The herpes simplex virus US11 protein effectively compensates for the γ1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the α subunit of eukaryotic translation initiation factor 2. J Virol 72:86208626.[PubMed]
46. Taddeo B, Zhang W, Lakeman F, Roizman B. 2004. Cells lacking NF-kappaB or in which NF-kappaB is not activated vary with respect to ability to sustain herpes simplex virus 1 replication and are not susceptible to apoptosis induced by a replication-incompetent mutant virus. J Virol 78:1161511621.[PubMed]
47. Kalamvoki M, Du T, Roizman B. 2014. Cells infected with herpes simplex virus 1 export to uninfected cells exosomes containing STING, viral mRNAs, and microRNAs. Proc Natl Acad Sci USA 111:E4991E4996.[PubMed]
48. Du T, Han Z, Zhou G, Roizman B. 2015. Patterns of accumulation of miRNAs encoded by herpes simplex virus during productive infection, latency, and on reactivation. Proc Natl Acad Sci USA 112:E49E55.[PubMed]
49. Du T, Zhou G, Khan S, Gu H, Roizman B. 2010. Disruption of HDAC/CoREST/REST repressor by dnREST reduces genome silencing and increases virulence of herpes simplex virus. Proc Natl Acad Sci USA 107:1590415909.[PubMed]
50. Chou J, Kern ER, Whitley RJ, Roizman B. 1990. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science 250:12621266.[PubMed]
51. Chou J, Roizman B. 1986. The terminal a sequence of the herpes simplex virus genome contains the promoter of a gene located in the repeat sequences of the L component. J Virol 57:629637.[PubMed]
52. Hesselgesser J, Horuk R. 1999. Chemokine and chemokine receptor expression in the central nervous system. J Neurovirol 5:1326.[PubMed]
53. Whitley RJ, Kern ER, Chatterjee S, Chou J, Roizman B. 1993. Replication, establishment of latency, and induced reactivation of herpes simplex virus γ 1 34.5 deletion mutants in rodent models. J Clin Invest 91:28372843.[PubMed]
54. Baringer JR, Swoveland P. 1973. Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med 288:648650.[PubMed]
55. Bastian FO, Rabson AS, Yee CL, Tralka TS. 1972. Herpesvirus hominis: isolation from human trigeminal ganglion. Science 178:306307.[PubMed]
56. Roizman B, Sears AE,. 1996. Herpes simplex viruses and their replication, p 22312295. In Fields BN, , et al (ed), Fields Virology. Lippincott-Raven Publishers, Philadelphia.
57. Stevens JG, Cook ML. 1971. Latent herpes simplex virus in spinal ganglia of mice. Science 173:843845.[PubMed]
58. Carton CA, Kilbourne ED. 1952. Activation of latent herpes simplex by trigeminal sensory-root section. N Engl J Med 246:172176.[PubMed]
59. Cushing H. 1905. Surgical aspects of major neuralgia of trigeminal nerve: a report of 20 cases of operation upon the Gasserian ganglion, with anatomic and physiologic notes on the consequences of its removal. JAMA XLIV:773779, 860–865, 920–929, 1002–1008.
60. Goodpasture EW. 1929. Herpetic infections with especial reference to involvement of the nervous system. Medicine 8:223243.
61. Pazin GJ, Ho M, Jannetta PJ. 1978. Reactivation of herpes simplex virus after decompression of the trigeminal nerve root. J Infect Dis 138:405409.[PubMed]
62. Roizman B, Sears AE. 1987. An inquiry into the mechanisms of herpes simplex virus latency. Annu Rev Microbiol 41:543571.[PubMed]
63. Selling B, Kibrick S. 1964. An outbreak of herpes simplex among wrestlers (herpes gladiatorum). N Engl J Med 270:979982.[PubMed]
64. Black FL. 1975. Infectious diseases in primitive societies. Science 187:515518.[PubMed]
65. Scott TFM, Steigman AJ, Convey JH. 1941. Acute infectious gingivostomatitis: etiology, epidemiology, and clinical pictures of a common disorder caused by the virus of herpes simplex. JAMA 117:9991005.
66. Bader C, Crumpacker CS, Schnipper LE, Ransil B, Clark JE, Arndt K, Freedberg IM. 1978. The natural history of recurrent facial-oral infection with herpes simplex virus. J Infect Dis 138:897965.[PubMed]
67. Glezen WP, Fernald GW, Lohr JA. 1975. Acute respiratory disease of university students with special reference to the etiologic role of Herpesvirus hominis. Am J Epidemiol 101:111121.[PubMed]
68. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. 1989. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 321:712.[PubMed]
69. Nahmias AJ, Lee FK, Beckman-Nahmias S. 1990. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 69:1936.[PubMed]
70. Norberg P, Tyler S, Severini A, Whitley R, Liljeqvist , Bergström T. 2011. A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus. PLoS One 6:e22527.[PubMed]
71. Ship II, Morris AL, Durocher RT, Burket LW. 1960. Recurrent aphthous ulcerations and recurrent herpes labialis in a professional school student population: I. Experience. Oral Surg Oral Med Oral Pathol 13:11911202.
72. Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuñiga R, Magaret AS, Wald A, Corey L, Celum C. 2007. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis 196:15001508.[PubMed]
73. Hale BD, Rendtorff RC, Walker LC, Roberts AN. 1963. Epidemic herpetic stomatitis in an orphanage nursery. JAMA 183:10681072.[PubMed]
74. Schmitt DL, Johnson DW, Henderson FW. 1991. Herpes simplex type 1 infections in group day care. Pediatr Infect Dis J 10:729733.[PubMed]
75. Josey WE, Nahmias AJ, Naib ZM. 1968. Genital infection with type-2 herpesvirus hominis. Am J Obstet Gynecol 101:718729.
76. Corey L, Adams HG, Brown ZA, Holmes KK. 1983. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 98:958972.[PubMed]
77. Xu F, Schillinger JA, Sternberg MR, Johnson RE, Lee FK, Nahmias AJ, Markowitz LE. 2002. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988–1994. J Infect Dis 185:10191024.[PubMed]
78. Reeves WC, Corey L, Adams HG, Vontver LA, Holmes KK. 1981. Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med 305:315319.[PubMed]
79. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. 1989. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 321:712.[PubMed]
80. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK, St Louis ME. 1997. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 337:11051111.[PubMed]
81. Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE. 2006. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296:964973.[PubMed]
82. Breinig MK, Kingsley LA, Armstrong JA, Freeman DJ, Ho M. 1990. Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis 162:299305.[PubMed]
83. Koutsky LA, Ashley RL, Holmes KK, Stevens CE, Critchlow CW, Kiviat N, Lipinski CM, Hanssen PW, Corey L. 1990. The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis 17:9094.[PubMed]
84. Sánchez-Martínez D, Schmid DS, Whittington W, Brown D, Reeves WC, Chatterjee S, Whitley RJ, Pellett PE. 1991. Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. J Infect Dis 164:11961199.[PubMed]
85. Nahmias AJ, Roizman B. 1973. Infection with herpes-simplex viruses 1 and 2. 1. N Engl J Med 289:667674, 719–725, 781–789.[PubMed]
86. Ekwo E, Wong YW, Myers M. 1979. Asymptomatic cervicovaginal shedding of herpes simplex virus. Am J Obstet Gynecol 134:102103.[PubMed]
87. Rattray MC, Corey L, Reeves WC, Vontver LA, Holmes KK. 1978. Recurrent genital herpes among women: symptomatic v. asymptomatic viral shedding. Br J Vener Dis 54:262265.[PubMed]
88. Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, Krieger JN, Corey L. 2000. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 342:844850.[PubMed]
89. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. 1987. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 316:14441449.[PubMed]
90. Koelle DM, Benedetti J, Langenberg A, Corey L. 1992. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med 116:433437.[PubMed]
91. Brock BV, Selke S, Benedetti J, Douglas JM Jr, Corey L. 1990. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA 263:418420.[PubMed]
92. Koutsky LA, Stevens CE, Holmes KK, Ashley RL, Kiviat NB, Critchlow CW, Corey L. 1992. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 326:15331539.[PubMed]
93. Kulhanjian JA, Soroush V, Au DS, Bronzan RN, Yasukawa LL, Weylman LE, Arvin AM, Prober CG. 1992. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med 326:916920.[PubMed]
94. Wald A, Zeh J, Selke S, Ashley RL, Corey L. 1995. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 333:770775.[PubMed]
95. Johnston C, Corey L. 2016. Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding. Clin Microbiol Rev 29:149161.[PubMed]
96. Johnston C, Zhu J, Jing L, Laing KJ, McClurkan CM, Klock A, Diem K, Jin L, Stanaway J, Tronstein E, Kwok WW, Huang ML, Selke S, Fong Y, Magaret A, Koelle DM, Wald A, Corey L. 2014. Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection. J Virol 88:49214931.[PubMed]
97. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. 1992. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 116:197202.[PubMed]
98. Holmberg SD, Stewart JA, Gerber AR, Byers RH, Lee FK, O'Malley PM, Nahmias AJ. 1988. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 259:10481050.[PubMed]
99. Hook EW III, Cannon RO, Nahmias AJ, Lee FF, Campbell CH Jr, Glasser D, Quinn TC. 1992. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis 165:251255.[PubMed]
100. Stamm WE, Handsfield HH, Rompalo AM, Ashley RL, Roberts PL, Corey L. 1988. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 260:14291433.[PubMed]
101. Martinez V, Caumes E. 2007. HSV therapy and HIV-1 reduction. N Engl J Med 356:23232324, author reply 2324.[PubMed]
102. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. 2002. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 186:17181725.[PubMed]
103. Brown ZA, Benedetti J, Ashley R, Burchett S, Selke S, Berry S, Vontver LA, Corey L. 1991. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 324:12471252.[PubMed]
104. Guinan ME, MacCalman J, Kern ER, Overall JC Jr, Spruance SL. 1981. The course of untreated recurrent genital herpes simplex infection in 27 women. N Engl J Med 304:759763.[PubMed]
105. Buchman TG, Roizman B, Adams G, Stover BH. 1978. Restriction endonuclease fingerprinting of herpes simplex virus DNA: a novel epidemiological tool applied to a nosocomial outbreak. J Infect Dis 138:488498.[PubMed]
106. Koelle D, Stanberry LS, Whitley RJ,. 2010. Herpes simplex vaccines, p 653671. In Levine G, , et al (ed), New Generation Vaccines. M.D. Informa Healthcare, New York.
107. Posavad CM, Koelle DM, Corey L. 1998. Tipping the scales of herpes simplex virus reactivation: the important responses are local. Nat Med 4:381382.[PubMed]
108. De Stasio PR, Taylor MW. 1990. Specific effect of interferon on the herpes simplex virus type 1 transactivation event. J Virol 64:25882593.[PubMed]
109. Holterman AX, Rogers K, Edelmann K, Koelle DM, Corey L, Wilson CB. 1999. An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection. J Virol 73:20582063.[PubMed]
110. Mester JC, Milligan GN, Bernstein DI,. 1996. The immunobiology of herpes simplex virus, p 4991. In Stanberry LR (ed), Genital and Neonatal Herpes. John Wiley and Sons Ltd, New York.
111. Biron CA, Byron KS, Sullivan JL. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320:17311735.[PubMed]
112. Lopez C, Arvin AM, Ashley R,. 1993. Immunity to herpesvirus infections in humans, p 397425. In Roizman B, Whitley RJ, Lopez C (ed), The Human Herpesviruses. Raven Press, New York.
113. Belz GT, Behrens GM, Smith CM, Miller JF, Jones C, Lejon K, Fathman CG, Mueller SN, Shortman K, Carbone FR, Heath WR. 2002. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 196:10991104.[PubMed]
114. Zhao X, Deak E, Soderberg K, Linehan M, Spezzano D, Zhu J, Knipe DM, Iwasaki A. 2003. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 197:153162.[PubMed]
115. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284:18351837.[PubMed]
116. Lund JM, Linehan MM, Iijima N, Iwasaki A. 2006. Cutting Edge: plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ. J Immunol 177:75107514.[PubMed]
117. Sato A, Linehan MM, Iwasaki A. 2006. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci USA 103:1734317348.[PubMed]
118. Abbo L, Vincek V, Dickinson G, Shrestha N, Doblecki S, Haslett PA. 2007. Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod. Clin Infect Dis 44:e25e27.[PubMed]
119. Dalloul A, Oksenhendler E, Chosidow O, Ribaud P, Carcelain G, Louvet S, Massip P, Lebon P, Autran B. 2004. Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood. J Clin Virol 30:329336.[PubMed]
120. Milligan GN, Bernstein DI. 1995. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology 212:481489.[PubMed]
121. Mueller SN, Jones CM, Smith CM, Heath WR, Carbone FR. 2002. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J Exp Med 195:651656.[PubMed]
122. Murphy BR,. 1998. Mucosal immunity to viruses, p 695707. In Ogra P, , et al (ed), Mucosal Immunology. Academic Press, New York.
123. Daheshia M, Feldman LT, Rouse BT. 1998. Herpes simplex virus latency and the immune response. Curr Opin Microbiol 1:430435.[PubMed]
124. Khanna KM, Bonneau RH, Kinchington PR, Hendricks RL. 2003. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18:593603.[PubMed]
125. Verjans GM, Hintzen RQ, van Dun JM, Poot A, Milikan JC, Laman JD, Langerak AW, Kinchington PR, Osterhaus AD. 2007. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc Natl Acad Sci USA 104:34963501.[PubMed]
126. Liu T, Khanna KM, Carriere BN, Hendricks RL. 2001. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J Virol 75:1117811184.[PubMed]
127. Suvas S, Azkur AK, Rouse BT. 2006. Qa-1b and CD94-NKG2a interaction regulate cytolytic activity of herpes simplex virus-specific memory CD8+ T cells in the latently infected trigeminal ganglia. J Immunol 176:17031711.[PubMed]
128. Koelle DM, Posavad CM, Barnum GR, Johnson ML, Frank JM, Corey L. 1998. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J Clin Invest 101:15001508.[PubMed]
129. Koelle DM, Schomogyi M, Corey L. 2000. Antigen-specific T cells localize to the uterine cervix in women with genital herpes simplex virus type 2 infection. J Infect Dis 182:662670.[PubMed]
130. Zhu J, Koelle DM, Cao J, Vazquez J, Huang ML, Hladik F, Wald A, Corey L. 2007. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J Exp Med 204:595603.[PubMed]
131. Stanberry LR, Cunningham AL, Mindel A, Scott LL, Spruance SL, Aoki FY, Lacey CJ. 2000. Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis 30:549566.[PubMed]
132. Hashido M, Kawana T. 1997. Herpes simplex virus-specific IgM, IgA and IgG subclass antibody responses in primary and nonprimary genital herpes patients. Microbiol Immunol 41:415420.[PubMed]
133. Stanberry L, Koelle D, Carpenter RS, Whitley R,. 2010. Herpes simplex vaccines. p 653671. In Levine GDM, Good M, Liu M, Nabel G, Nataro J, Rappuoli R (ed), New Generation Vaccines. Informa Healthcare, New York.
134. Stanberry LR, Spruance SL, Cunningham AL, Bernstein DI, Mindel A, Sacks S, Tyring S, Aoki FY, Slaoui M, Denis M, Vandepapeliere P, Dubin G, for the GlaxoSmithKline Herpes Vaccine Efficacy Study Group. 2002. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 347:16521661.[PubMed]
135. Stern H, Elek SD, Millar DM, Anderson HF. 1959. Herpetic whitlow, a form of cross-infection in hospitals. Lancet 274:871874.[PubMed]
136. Seidlin M, Takiff H, Rooney JF, Felser JM, Smith HA, Roane P, Johnson F, Hallahan C, Ostrove JM, Nusinoff-Lehrman S. 1989. Effect of oral acyclovir treatment on symptomatic and asymptomatic virus shedding in recurrent genital herpes. Sex Transm Dis 16:107113.[PubMed]
137. Straus SE, Takiff HE, Seidlin M, Bachrach S, Lininger L, DiGiovanna JJ, Western KA, Smith HA, Lehrman SN, Creagh-Kirk T, Alling DW. 1984. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. N Engl J Med 310:15451550.[PubMed]
138. Sullender WM, Miller JL, Yasukawa LL, Bradley JS, Black SB, Yeager AS, Arvin AM. 1987. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J Infect Dis 155:2837.[PubMed]
139. Tuxen DV, Cade JF, McDonald MI, Buchanan MR, Clark RJ, Pain MC. 1982. Herpes simplex virus from the lower respiratory tract in adult respiratory distress syndrome. Am Rev Respir Dis 126:416419.[PubMed]
140. Wade JC, Meyers JD. 1983. Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation. Ann Intern Med 98:921925.[PubMed]
141. Wade JC, Newton B, McLaren C, Flournoy N, Keeney RE, Meyers JD. 1982. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med 96:265269.[PubMed]
142. Weston WL, Brice SL, Jester JD, Lane AT, Stockert S, Huff JC. 1992. Herpes simplex virus in childhood erythema multiforme. Pediatrics 89:3234.[PubMed]
143. Wheeler CE Jr, Cabaniss WH Jr. 1965. Epidemic cutaneous herpes simplex in wrestlers (herpes gladiatorum). JAMA 194:993997.[PubMed]
144. Whitley RJ, Alford CA, Hirsch MS, Schooley RT, Luby JP, Aoki FY, Hanley D, Nahmias AJ, Soong SJ. 1986. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 314:144149.[PubMed]
145. Whitley R, Arvin A, Prober C, Corey L, Burchett S, Plotkin S, Starr S, Jacobs R, Powell D, Nahmias A, Sumaya C, Edwards K, Alford C, Caddell G, Soong S-J The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. 1991. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med 324:450454.[PubMed]
146. Buddingh GJ, Schrum DI, Lanier JC, Guidry DJ. 1953. Studies of the natural history of herpes simplex infections. Pediatrics 11:595610.[PubMed]
147. Cesario TC, Poland JD, Wulff H, Chin TD, Wenner HA. 1969. Six years experience with herpes simplex virus in a children's home. Am J Epidemiol 90:416422.[PubMed]
148. Lindgren KM, Douglas RG Jr, Couch RB. 1968. Significance of Herpesvirus hominis in respiratory secretions of man. N Engl J Med 278:517523.[PubMed]
149. Young SK, Rowe NH, Buchanan RA. 1976. A clinical study for the control of facial mucocutaneous herpes virus infections. I. Characterization of natural history in a professional school population. Oral Surg Oral Med Oral Pathol 41:498507.[PubMed]
150. Hatherley LI, Hayes K, Hennessy EM, Jack I. 1980. Herpes virus in an obstetric hospital: I: Herpetic eruptions. Med J Aust 2:205208.[PubMed]
151. Hatherley LI, Hayes K, Jack I. 1980. Herpes virus in an obstetric hospital. II: Asymptomatic virus excretion in staff members. Med J Aust 2:273275.[PubMed]
152. Pass RF, Whitley RJ, Whelchel JD, Diethelm AG, Reynolds DW, Alford CA. 1979. Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J Infect Dis 140:487492.[PubMed]
153. Spruance SL, Overall JC Jr, Kern ER, Krueger GG, Pliam V, Miller W. 1977. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med 297:6975.[PubMed]
154. Corey L. 1982. The diagnosis and treatment of genital herpes. JAMA 248:10411049.[PubMed]
155. Corey L, Holmes KK. 1983. Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention. Ann Intern Med 98:973983.[PubMed]
156. Bryson YJ, Dillon M, Lovett M, Acuna G, Taylor S, Cherry JD, Johnson BL, Wiesmeier E, Growdon W, Creagh-Kirk T, Keeney R. 1983. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med 308:916921.[PubMed]
157. Cone RW, Hobson AC, Brown Z, Ashley R, Berry S, Winter C, Corey L. 1994. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA 272:792796.[PubMed]
158. Kimberlin DW, Acosta EP, Sánchez PJ, Sood S, Agrawal V, Homans J, Jacobs RF, Lang D, Romero JR, Griffin J, Cloud GA, Lakeman FD, Whitley RJ National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. 2008. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis 197:836845.[PubMed]
159. Young EJ, Killam AP, Greene JF Jr. 1976. Disseminated herpesvirus infection. Association with primary genital herpes in pregnancy. JAMA 235:27312733.[PubMed]
160. Nahmias AJ, Josey WE, Naib ZM, Freeman MG, Fernandez RJ, Wheeler JH. 1971. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 110:825837.[PubMed]